Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Primary Care

Journal Scan / Research · August 31, 2021

Prevalence of Preeclampsia Unchanged After Implementation of Prophylactic Aspirin for Pregnant Women With Preexisting Diabetes

Diabetes Care


Additional Info

Diabetes Care
Unchanged Prevalence of Preeclampsia After Implementation of Prophylactic Aspirin for All Pregnant Women With Preexisting Diabetes: A Prospective Cohort Study
Diabetes Care 2021 Aug 15;[EPub Ahead of Print], NC Do, M Vestgaard, B Ásbjörnsdóttir, SK Nørgaard, LLT Andersen, DM Jensen, L Ringholm, P Damm, ER Mathiesen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading